EpCAM | CD133 | |||||
---|---|---|---|---|---|---|
Low (n = 6) | High (n = 10) | P | Low (n = 4) | High (n = 12) | P | |
Age (year) | 58(53–65) | 56(48–68) | 0.236 | 52(48–57) | 58(49–68) | 0.070 |
Gender (F/M) | 1/5 | 1/9 | 0.696 | 0/4 | 2/12 | 0.383 |
AFP (ng/ml) | 1333(4–7254) | 256(3–2000) | 0.289 | 297(8–43) | 870(3–7254) | 0.177 |
Interval between | 189(82–345) | 224(73–337) | 0.479 | 260(188–327) | 194(73–377) | 0.217 |
TACE and Tx (days) | ||||||
More than one TACE | 1/6 | 3/10 | 0.639 | 2/4 | 2/12 | 0.329 |
Tumor Size (mm) | 45(25–76) | 34(20–55) | 0.181 | 36(32–40) | 39(20–76) | 0.744 |
Tumor differentiation | 0.024 | 0.834 | ||||
Well | 0 | 1 | 0 | 1 | ||
Moderately | 6 | 3 | 3 | 8 | ||
Poor | 0 | 6 | 1 | 3 | ||
TNM Stages | 0.302 | 0.248 | ||||
I | 4 | 4 | 1 | 7 | ||
II | 2 | 6 | 3 | 5 |